Mechanism of direct bicarbonate transport by the CFTR anion channel

Slides:



Advertisements
Similar presentations
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Advertisements

Volume 93, Issue 7, Pages (October 2007)
External Tetraethylammonium As a Molecular Caliper for Sensing the Shape of the Outer Vestibule of Potassium Channels  Frank Bretschneider, Anja Wrisch,
Bioelectric effects of quinine on polarized airway epithelial cells
Volume 80, Issue 2, Pages (February 2001)
Jinny J. Guo, David A. Stoltz, Vivian Zhu, Kenneth A. Volk, Jeffrey L
Ivacaftor potentiation of multiple CFTR channels with gating mutations
Volume 2, Issue 3, Pages (September 1998)
Deleterious impact of hyperglycemia on cystic fibrosis airway ion transport and epithelial repair  Claudia Bilodeau, Olivier Bardou, Émilie Maillé, Yves.
Evaluation of a systems biology approach to identify pharmacological correctors of the mutant CFTR chloride channel  Emanuela Pesce, Giulia Gorrieri,
CFTR mutation in an Arab patient: Clinical and functional features of 875+1G→A/875+1G→A genotype  Elide Spinelli, Manuela Seia, Paola Melotti, Eleonora.
Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function  Fredrick Van Goor, Haihui Yu, Bill.
Bioelectric effects of quinine on polarized airway epithelial cells
Volume 118, Issue 6, Pages (June 2000)
Tetraethylammonium Block of the BNC1 Channel
Z. Kopeikin, Z. Yuksek, H.-Y. Yang, S.G. Bompadre 
The relationship between cell proliferation, Cl− secretion, and renal cyst growth: A study using CFTR inhibitors  Hongyu Li, Iain A. Findlay, David N.
CFTR: Effect of ICL2 and ICL4 amino acids in close spatial proximity on the current properties of the channel  Arnaud Billet, Jean-Paul Mornon, Mathilde.
FPL Modification of CaV1
Presence of store-operated Ca2+ entry in C57BL/6J mouse ventricular myocytes and its suppression by sevoflurane  A. Kojima, H. Kitagawa, M. Omatsu-Kanbe,
Volume 47, Issue 6, Pages (September 2005)
Targeting ion channels in cystic fibrosis
Volume 65, Issue 1, Pages (January 2004)
Volume 116, Issue 6, Pages (June 1999)
Cirrhosis and other liver disease in cystic fibrosis
Curcumin and genistein additively potentiate G551D-CFTR
The patch-clamp and planar lipid bilayer techniques: powerful and versatile tools to investigate the CFTR Cl− channel  David N. Sheppard, Michael A. Gray,
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Vitamin A and lung function in CF
Involvement of ion channels in human eosinophil respiratory burst
Narae Shin, Heun Soh, Sunghoe Chang, Do Han Kim, Chul-Seung Park 
A.H. Gifford  Journal of Cystic Fibrosis 
Shaoyan Zhang, Neel K. Ranganath, Daniel Skinner, David M
Wolfgang Nonner, Duan P. Chen, Bob Eisenberg  Biophysical Journal 
Volume 15, Issue 7, Pages (July 2008)
Lily Paemka, Brian N. McCullagh, Mahmoud H. Abou Alaiwa, David A
Molecular Basis for Kir6.2 Channel Inhibition by Adenine Nucleotides
Christoph Randak, Michael J Welsh  Cell 
Transepithelial fluctuation analysis of chloride secretion
Carlos A. Obejero-Paz, Stephen W. Jones, Antonio Scarpa 
Ca2+- and Voltage-Dependent Gating of Ca2+- and ATP-Sensitive Cationic Channels in Brain Capillary Endothelium  László Csanády, Vera Adam-Vizi  Biophysical.
Polyvalent Cations as Permeant Probes of MIC and TRPM7 Pores
A Large-Conductance Anion Channel of the Golgi Complex
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
KCNKØ: Single, Cloned Potassium Leak Channels Are Multi-Ion Pores
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Molecular Determinants of Anion Selectivity in the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Pore  Paul Linsdell, Alexandra.
Volume 88, Issue 3, Pages (March 2005)
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
A new method of sweat testing: the CF Quantum®sweat test
Volume 77, Issue 2, Pages (August 1999)
Volume 16, Issue 5, Pages (May 1996)
Fredrik Elinder, Michael Madeja, Hugo Zeberg, Peter Århem 
Volume 121, Issue 6, Pages (December 2001)
Inhibition of αβ Epithelial Sodium Channels by External Protons Indicates That the Second Hydrophobic Domain Contains Structural Elements for Closing.
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
P. aeruginosa LPS stimulates calcium signaling and chloride secretion via CFTR in human bronchial epithelial cells  J.M. Buyck, V. Verriere, R. Benmahdi,
Michael W. Konstan, David J. Pasta, Jeffrey S. Wagener, Donald R
Inwardly Rectifying Current-Voltage Relationship of Small-Conductance Ca2+-Activated K+ Channels Rendered by Intracellular Divalent Cation Blockade  Heun.
CFTR modulators and pregnancy: Our work has only just begun
Strategies to investigate the mechanism of action of CFTR modulators
CFTR, investigated with the two-electrode voltage-clamp technique: the importance of knowing the series resistance  Georg Nagel  Journal of Cystic Fibrosis 
Volume 25, Issue 3, Pages (March 2000)
Antonella Gradogna, Michael Pusch  Biophysical Journal 
Absence of a gender gap in survival
R. D. Gray, M. Imrie, A. C. Boyd, D. Porteous, J. A. Innes, A. P
Volume 97, Issue 7, Pages (October 2009)
Yassine El Hiani, Paul Linsdell  Biophysical Journal 
Stimulatory Action of Internal Protons on Slo1 BK Channels
Liping He, Jerod Denton, Keith Nehrke, Kevin Strange 
Presentation transcript:

Mechanism of direct bicarbonate transport by the CFTR anion channel Lin Tang, Mohammad Fatehi, Paul Linsdell  Journal of Cystic Fibrosis  Volume 8, Issue 2, Pages 115-121 (March 2009) DOI: 10.1016/j.jcf.2008.10.004 Copyright © 2008 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Bicarbonate permeability of CFTR (A–C) Example leak-subtracted macroscopic I–V relationships for wild type CFTR under different ionic conditions, as indicated: in (A) 150 mM HCO3− intracellular, 154 mM Cl− extracellular; in (B) 50 mM HCO3− intracellular, 54 mM Cl− extracellular; and in (C) 50 mM HCO3− intracellular, 4 mM Cl− +50 mM gluconate extracellular. In all cases the intracellular solution also contained 4 mM Cl−. Under each of these conditions, negative currents (representing anion efflux across the membrane) are carried predominantly by the movement of HCO3− ions. (D) Example single channel currents carried by HCO3− efflux under the same ionic conditions used in (C), at membrane potentials of 0 mV and −60 mV as indicated. The closed state of the channel is indicated by the line to the left. (E) Mean single channel I–V relationship measured under these conditions. Standard errors are smaller than the size of the symbols and hence not shown. Mean of data from 3–5 patches. Journal of Cystic Fibrosis 2009 8, 115-121DOI: (10.1016/j.jcf.2008.10.004) Copyright © 2008 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Block of bicarbonate efflux by the specific CFTR inhibitor CFTRinh-172. (A) Example leak-subtracted I–V relationship recorded under the same ionic conditions used in Fig. 1C, illustrating current carried by HCO3− efflux. Currents were recorded before (control) and following addition of 3 μM CFTRinh-172 to the intracellular (bath) solution. (B) CFTRinh-172 concentration-inhibition relationship under these conditions, showing the fraction of control current remaining following addition of different concentrations of the inhibitor. The data have been fitted by the equation: fractional current=1/(1+{[inh]/Kd}nH), where [inh] is the concentration of CFTRinh-172, Kd is 0.63 μM, and nH, the slope factor or Hill coefficient, is 0.83. Journal of Cystic Fibrosis 2009 8, 115-121DOI: (10.1016/j.jcf.2008.10.004) Copyright © 2008 European Cystic Fibrosis Society. Terms and Conditions

Fig. 3 Block of chloride and bicarbonate currents (A, B) Example leak-subtracted macroscopic I–V relationships recorded with 54 mM Cl− (A) or 50 mM HCO3− plus 4 mM Cl− in the intracellular solution, and 4 mM Cl− plus 50 mM gluconate in the extracellular solution. In each case, currents were recorded before (a) and following (b) addition of the named CFTR channel blocker to the intracellular solution: DNDS (100 μM, left panels), glibenclamide (30 μM, centre panels), or suramin (10 μM, right panels). (C) Mean fraction of control current remaining following addition of these concentrations of blockers, both for Cl− currents (○) and HCO3− currents (●), as a function of membrane potential. Asterisks indicate the voltage range over which the fractional block was significantly different for HCO3− versus Cl− currents. Mean of data from 3–5 patches. Journal of Cystic Fibrosis 2009 8, 115-121DOI: (10.1016/j.jcf.2008.10.004) Copyright © 2008 European Cystic Fibrosis Society. Terms and Conditions

Fig. 4 Mutations in the pore decrease the blocker sensitivity of bicarbonate currents (A) Example leak-subtracted I–V relationship recorded under the same ionic conditions used in Fig. 3B in K95Q-CFTR (left, centre panels) or R303Q-CFTR (right panel). In each case, currents were recorded before (a) and following (b) addition of the named CFTR channel blocker to the intracellular solution: DNDS (100 μM, left panel), glibenclamide (30 μM, centre panel), or suramin (10 μM, right panel), as shown for wild type CFTR in Fig. 3B. (B) Mean fraction of control current remaining following addition of these concentrations of blockers, in wild type (●; taken from Fig. 3C) or the named mutant (○). In each case fractional block was significantly different in the named mutant versus wild type across the entire voltage range studied. Mean of data from 3–5 patches. Journal of Cystic Fibrosis 2009 8, 115-121DOI: (10.1016/j.jcf.2008.10.004) Copyright © 2008 European Cystic Fibrosis Society. Terms and Conditions

Fig. 5 Bicarbonate permeability of CF mutant forms of CFTR Example leak-subtracted macroscopic I–V relationships for G178R, G551S, and H620Q-CFTR under the same ionic conditions used in Fig. 1B. Journal of Cystic Fibrosis 2009 8, 115-121DOI: (10.1016/j.jcf.2008.10.004) Copyright © 2008 European Cystic Fibrosis Society. Terms and Conditions